{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2001-D-0219\" sorted by posted_date descending", "rows": [["FDA-2001-D-0219-0015", "FDA", "FDA-2001-D-0219", "Use of Data Monitoring Committees in Clinical Trials; Draft Guidance for Industry; Availability; Agency\nInformation Collection Activities; Proposed Collection; Comment Request", "Notice", "Notice of Availability", "2024-02-13T05:00:00Z", 2024, 2, null, null, "2024-02-13T14:42:27Z", "2024-02849", 0, 0, "0900006486404168"], ["FDA-2001-D-0219-0016", "FDA", "FDA-2001-D-0219", "Use of Data Monitoring Committees in Clinical Trials; Guidance for Industry; Draft Guidance", "Other", "Guidance", "2024-02-13T05:00:00Z", 2024, 2, "2024-02-13T05:00:00Z", "2024-04-16T03:59:59Z", "2025-06-06T09:00:07Z", null, 1, 0, "0900006486404548"], ["FDA-2001-D-0219-0014", "FDA", "FDA-2001-D-0219", "Tab E - Tab E-Guidance for Industry, ICR E6, Good Clinica1 Practice: Consolidated Guidance, April 1996 [Guidance of 3/28/2006]", "Supporting & Related Material", "BKG-Background Material", "2010-05-10T04:00:00Z", 2010, 5, null, null, "2010-05-10T20:08:54Z", null, 0, 0, "09000064804e4eb3"], ["FDA-2001-D-0219-0013", "FDA", "FDA-2001-D-0219", "Tab D - Guidance for Industry, ICH E9, Statistical Principles forClinical Trials, September 1998 [Guidance of 3/28/2006]", "Supporting & Related Material", "BKG-Background Material", "2010-05-10T04:00:00Z", 2010, 5, null, null, "2010-05-10T20:08:52Z", null, 0, 0, "09000064804e4eac"], ["FDA-2001-D-0219-0010", "FDA", "FDA-2001-D-0219", "Clinical Trial Sponsors on the Establishment & Operation of Clinical Trial Monitoring Committees, November 2201 - Draft Guidance", "Supporting & Related Material", "GDL-Guidance", "2010-05-10T04:00:00Z", 2010, 5, null, null, "2010-05-10T18:54:00Z", null, 0, 0, "09000064804e4dee"], ["FDA-2001-D-0219-0011", "FDA", "FDA-2001-D-0219", "List of References [Guidance for Clinical Trial SponsorsEstablishment & Operation of Clinical Trial Monitoring Committees 3/28/2006]", "Supporting & Related Material", "BKG-Background Material", "2010-05-10T04:00:00Z", 2010, 5, null, null, "2010-05-10T19:48:22Z", null, 0, 0, "09000064804e4ea1"], ["FDA-2001-D-0219-0012", "FDA", "FDA-2001-D-0219", "Tab C - DHHS, Finaneial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection May 5, 2004. [Guidance of 3/28/2006]", "Supporting & Related Material", "BKG-Background Material", "2010-05-10T04:00:00Z", 2010, 5, null, null, "2010-05-10T19:45:19Z", null, 0, 0, "09000064804e4ea3"], ["FDA-2001-D-0219-0009", "FDA", "FDA-2001-D-0219", "Agency Information Collection Activities; Announcement of Office  of Management and Budget Approval; Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees", "Notice", "NAL-Notice of Approval", "2006-07-31T04:00:00Z", 2006, 7, "2006-07-28T04:00:00Z", null, "2010-05-10T16:54:40Z", null, 0, 0, "09000064804e4ed0"], ["FDA-2001-D-0219-0007", "FDA", "FDA-2001-D-0219", "Supporting Statement", "Supporting & Related Material", "SS-Supporting Statement", "2006-07-31T04:00:00Z", 2006, 7, null, null, "2008-04-25T02:28:20Z", null, 0, 0, "09000064804e4ecb"], ["FDA-2001-D-0219-0008", "FDA", "FDA-2001-D-0219", "Supporting Statement", "Supporting & Related Material", "SS-Supporting Statement", "2006-07-31T04:00:00Z", 2006, 7, null, null, "2008-04-25T02:28:19Z", null, 0, 0, "09000064804e4ece"], ["FDA-2001-D-0219-0005", "FDA", "FDA-2001-D-0219", "Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability", "Notice", "NAD-Notice of Availability of Data", "2006-03-28T05:00:00Z", 2006, 3, "2006-03-27T05:00:00Z", null, "2010-05-10T16:50:29Z", null, 0, 0, "09000064804e4ec0"], ["FDA-2001-D-0219-0006", "FDA", "FDA-2001-D-0219", "Guidance for Clinical Trial Sponsors; Establishment and Operation of Clinical Trial Data Monitoring Committees, March 2006", "Supporting & Related Material", "GDL-Guidance", "2006-03-28T05:00:00Z", 2006, 3, null, null, "2010-05-10T20:21:50Z", null, 0, 0, "09000064804e4ec4"], ["FDA-2001-D-0219-0003", "FDA", "FDA-2001-D-0219", "Guidance for Clinical Trial Sponsors; Establishment and Operation of Clinical Trial Data Monitoring Committee December 2005 - Draft Guidance", "Supporting & Related Material", "GDL-Guidance", "2006-01-10T05:00:00Z", 2006, 1, null, null, "2010-05-10T18:57:16Z", null, 0, 0, "09000064804e4e9c"], ["FDA-2001-D-0219-0004", "FDA", "FDA-2001-D-0219", "Agency Information Collection Activities; Submission for Office", "Notice", "N-Notice", "2006-01-10T05:00:00Z", 2006, 1, null, null, "2010-05-10T16:43:43Z", null, 0, 0, "09000064804e4e9e"], ["FDA-2001-D-0219-0002", "FDA", "FDA-2001-D-0219", "Draft Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability", "Notice", "NAD-Notice of Availability of Data", "2001-11-20T05:00:00Z", 2001, 11, "2001-11-19T05:00:00Z", "2002-02-20T04:59:59Z", "2010-05-10T16:34:55Z", null, 0, 0, "09000064804e4e02"], ["FDA-2001-D-0219-0001", "FDA", "FDA-2001-D-0219", "Draft FDA Guidance on the Estabtishment and Operation of Clinical Trial Data Monitoring Committees; Public Meeting", "Notice", "NM-Notice of Meeting", "2001-11-05T05:00:00Z", 2001, 11, null, null, "2010-05-10T16:33:19Z", null, 0, 0, "09000064804e4d7b"]], "truncated": false, "filtered_table_rows_count": 16, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2001-D-0219"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2001-D-0219", "results": [{"value": "FDA", "label": "FDA", "count": 16, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2001-D-0219", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2001-D-0219", "results": [{"value": 2006, "label": 2006, "count": 7, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&posted_year=2006", "selected": false}, {"value": 2010, "label": 2010, "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&posted_year=2010", "selected": false}, {"value": 2001, "label": 2001, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&posted_year=2001", "selected": false}, {"value": 2024, "label": 2024, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&posted_year=2024", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "title", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet=title"}, {"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2001-D-0219&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 237.14016703888774, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}